CorVel Insider Sale of $130K Comes Amid 50% One-Year Stock Drop. Here's What Investors Should Know
Key Points
The chief information officer of Cervel reported selling 2,400 shares for a total of $130,000, based on a weighted average price of $54.00 per share on March 16, 2026.
The entire transaction involved direct holdings via option exercise and immediate sale; no indirect entities were involved.
This sale reflects continued portfolio management at reduced capacity, leaving the CIO with 7,050 shares of directly owned common stock valued at $379,000 as of the transaction date.
- 10 stocks we like better than CorVel ›
Shishin Maxim, the chief information officer of CorVel (NASDAQ:CRVL), reported the exercise and immediate sale of 2,400 shares of common stock for a total transaction value of approximately $130,000 on March 16, 2026, according to a SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold (direct) | 2,400 |
| Transaction value | $130,000 |
| Post-transaction common shares (direct) | 7,050 |
| Post-transaction value (direct ownership) | ~$379K |
Transaction value based on SEC Form 4 weighted average purchase price ($54.00); post-transaction value based on March 16, 2026 market close ($54.00).
Key questions
- What was the structure of this transaction?
The transaction consisted of an option exercise for 2,400 shares of common stock, immediately followed by a sale of the same number of shares; no indirect holdings or entities participated. - How does this trade affect Maxim's ownership in CorVel Corporation?
Direct holdings declined from 9,450 to 7,050 shares, a reduction of 25.40% of Maxim’s direct common stock stake, with no remaining indirect or derivative equity exposure reported. - What is the market context for this transaction?
The sale occurred when shares were priced at around $54.00 per share, with CorVel having experienced a one-year total return of -50% as of March 16, 2026, indicating the sale took place amid a period of share price decline. - Does this transaction represent a deviation from prior activity?
No; while the number of shares sold is lower than some past transactions, the reduction aligns with the diminished share base following previous dispositions, reflecting routine portfolio management rather than escalation.
Company overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $941.49 million |
| Net income (TTM) | $105.73 million |
Company snapshot
- CorVel provides workers' compensation, auto, liability, and health solutions, including medical fee auditing, provider management, utilization review, pharmacy services, and claims management.
- The firm operates a technology-driven model leveraging artificial intelligence and analytics to manage healthcare claims and optimize medical cost containment for clients.
- It serves employers, third-party administrators, insurance companies, and government agencies seeking to control healthcare and insurance-related expenses.
CorVel Corporation is a leading provider of technology-enabled healthcare management and insurance solutions, with a focus on cost containment and process optimization for claims. The company leverages advanced analytics and automation to deliver efficient, scalable services to a diverse client base. Its strategic emphasis on innovation and operational efficiency supports its competitive position in the insurance services sector.
What this transaction means for investors
With CorVel shares down roughly 50% over the past year, any insider selling might draw attention, but the structure here matters more than the headline, and this sale ultimately looks like routine liquidity tied to compensation rather than a signal of deteriorating conviction, even if the optics are harsher given the stock’s steep decline.
At CorVel Corporation, underlying performance has held up better than the stock might suggest. Revenue for the most recent quarter reached $236 million, up from $228 million a year earlier, while diluted EPS ticked up to $0.47 from $0.46. Over the first nine months of the fiscal year, revenue climbed 7% to $710 million, and EPS rose 16% to $1.53, reflecting steady operating execution despite macro pressure. The company also exited the quarter with $230 million in cash and no debt, underscoring a strong balance sheet.
The takeaway for long-term investors is that price action and fundamentals have diverged. This type of option-related sale is common and does not necessarily reflect sentiment. The more important question is whether CorVel can sustain growth through its AI-driven claims platform. If it can, the current drawdown may prove more about a sentiment reset than structural weakness.
Should you buy stock in CorVel right now?
Before you buy stock in CorVel, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CorVel wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $490,325!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,074,070!*
Now, it’s worth noting Stock Advisor’s total average return is 900% — a market-crushing outperformance compared to 184% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of March 25, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CorVel. The Motley Fool has a disclosure policy.
Recommended Articles
